Le Lézard
Classified in: Health
Subject: SVY

Endoscopy Devices Market Prognosticated to be 44.32 Billion USD by 2025


LAS VEGAS, June 19, 2018 /PRNewswire/ --

The report "Endoscopy Devices Market by Product (Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopes, and Robot-Assisted Endoscopes), Application (Gastrointestinal Endoscopy, Laparoscopy, Urology Endoscopy, Arthroscopy, Obstetrics/Gynecology Endoscopy, Mediastinoscopy, Bronchoscopy, Laryngoscopy, Otoscopy, and Other Applications), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Mobile Endoscopy Units, and Office Based Setting) - Global Forecast to 2025", issued by Crystal Market Research, the market size for the Endoscopy Devices is proposed to grow from an expected USD 26.8 billion in 2016 to USD 44.32 billion by 2025, at a CAGR of 5.89% from 2016 to 2025.

     (Logo: http://mma.prnewswire.com/media/525277/Crystal_Market_Research_Logo.jpg )

Browse in-depth TOC on "Endoscopy Devices Market"
https://www.crystalmarketresearch.com/report/endoscopy-devices-market

Flexible endoscopes were leading in the product segment of endoscopy devices market in 2015 and is anticipated to sustain the same market position. 

Varied use of flexible endoscopes for treating and diagnosing several diseases like diseases related to gallbladder which is followed by several patients preferring this procedure since it promotes shorter time for recovery owing to its reduced post-operative complications. These devices also have the potential to go into the in-depth cavities and viscera which is otherwise not perceptible to the naked eye. Also, in recent times, capsule endoscopes are emerging and have opened up novel opportunities in the field of endoscopy.

Gastrointestinal endoscopy application is estimated to grow at a most rapid CAGR of 5.61% 

Also, laparoscopy segment is prognosticated to spawn a greater revenue during the forecast period. The reason is attributed to the ascending demand of each as the increase in aged population is directly proportionate to the escalation in number of GI tract diseases.

Grab The Sample Copy of The Report Here: https://www.crystalmarketresearch.com/report-sample/HC06140

In terms of End User, the Hospital segment is predicted to uphold its domination in the analysis period. 

Amongst the other end users of the endoscopy devices market, hospital segment leads, owing to the presence of varied endoscopy facilities and preferred reimbursement policies. Majority hospitals are technologically enhanced and well-equipped and have the latest endoscopic devices. Nevertheless, shortage of skilled labor which are required to function the endoscopy devices having advanced technology is termed to considerably restrain the global market.

North America will dominate other regions in the race of endoscopy devices global market, followed by Europe. 

In North America, the United States alone was responsible for more than 92% market share in 2015. This is owing to the increasing incidences of chronic diseases along with the rise in old-age population, escalated rate of adoption of technologically enhanced devices, and more and more awareness pertaining to the advantages of the endoscopes. In Asia Pacific, Japan is a major contributor to the lucrative market share of the Asia-Pacific endoscopy devices market.

Bigger market players such as Olympus Corporation has a stronger hold in almost all major countries owing to the introduction of novel technologies and products which render the initial advantage. For instance, Olympus launched endoscopes with narrow band imaging (NBI), which enables the user to gauge more precision on the vision field. A few of the other market player in this industry are Medtronic plc, US Endoscopy, Ethicon US, LLC., Cook Group Incorporated, Olympus Corporation, Richard Wolf GmbH, FUJIFILM Holdings Corporation, Smith & Nephew PLC, KARL STORZ GmbH & Co. KG, PENTAX Medical, Boston Scientific Corporation, Stryker Corporation,  CONMED Corporation, B. Braun Melsungen AG and Siemens AG.

Know more about the: Endoscopy Devices Market

About Crystal Market Research: 

Crystal Market Research is a market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:
Judy S.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
International Number: +1-347-352-0883
Email: [email protected]
Blog: https://blog.crystalmarketresearch.com
Website: http://www.crystalmarketresearch.com


SOURCE Crystal Market Research


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: